Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 21, 2020
Vectura Group announced an expansion of its capabilities to handle and develop HPAPIs at its facility in Chippenham, U.K.
read more
Vectura announced three appointments to its business development team.
read more
Friday, December 18, 2020
Vectura has announced its partner Hikma has launched its generic version of GlaxoSmithKline’s Advair Diskus, 100mcg/50mcg and 250mcg/50mcg doses, in the US.
read more
Vectura Group announced Mark Bridgewater has been appointed as Chief Commercial Officer, a newly-created role focused in the Company.
read more
Monday, February 10, 2020
Vectura Group announced Sharon Johnson has been appointed to the position of Executive Vice President for Delivery Management, a newly-created leadership role.
read more
Vectura and Inspira Pharmaceuticals have announced an agreement to develop an inhaled formulation of Inspira’s lead drug candidate for the potential treatment of COVID-19.
read more
Tuesday, November 26, 2024
VectorBuilder, a provider of end-to-end gene delivery services, and Sartorius, a provider of life science research service for the biopharmaceutical industry, announced a strategic cooperation agreement.
read more
Vector Laboratories has opened its new facility in Newark, California, where it will relocate its corporate headquarters this year. The relocation is accompanied by the rebranding and launch of a new corporate website.
read more
Thursday, October 19, 2017
Vector Laboratories announced the availability of a new guide for the growing field of immunofluorescence.
read more
Wednesday, November 14, 2018
Vector Laboratories has achieved ISO 9001:2015 certification.
read more
Vectalys and FlashCell have merged to create Flash Therapeutics, a new privately held gene therapy company developing gene and cell therapeutics.
read more
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform technology, announced the opening of its first, state-of-the-art manufacturing facility in Brisbane, Queensland.
read more
Friday, December 05, 2014
VAXIMM AG, a Swiss-German biotech company focusing on oral cancer vaccines, announced today follow-on data from the first clinical trial of its investigational oral T-cell vaccine VXM01. Data of a trial extension of the randomized, placebo-controlled...
read more
A government data warehouse that stores personal information on millions of HealthCare.gov customers is raising privacy concerns at a time when major breaches have become distressingly common.
read more
Thursday, January 08, 2026
Rentschler Biopharma and VarmX announced a collaboration to manufacture VarmX’s lead program, VMX-C001, for Phase 3 development and potential commercialization. VMX-C001 is a novel treatment to restore blood coagulation in patients requiring urgent ...
read more